The research & development by business enterprise, pharmaceutical industry in current ppp $ in Lithuania is currently 0.29 million, a decrease of 1.12 million (-79.4%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Lithuania
No matching regions
Similar regions to Lithuania
Business R&D pharmaceutical in current PPP $
More indicators for Lithuania
Government R&D in security as % of government support
1.91%
-4.42%
(2021)
Higher-education-finacing R&D financed by general university in local currency
1,069.18M
+108.85M
(2021)
R&D financed by rest of the world in local currency
1,953.96M
+203.99M
(2021)
Government R&D financed by rest of the world in local currency
293.33M
-57.43M
(2021)
Business R&D financed by rest of the world in local currency
1,062.50M
+332.47M
(2021)
Non-profit R&D growth rate
-19.97%
+24.23%
(1999)
Lithuania Business R&D pharmaceutical in current PPP $ between 2008 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 0.29M | -1.12M |
| 2020 | 1.41M | -6.61M |
| 2019 | 8.02M | +6.22M |
| 2018 | 1.80M | +0.25M |
| 2017 | 1.55M | +0.38M |
| 2016 | 1.17M | -3.87M |
| 2015 | 5.04M | -12.01M |
| 2014 | 17.05M | +11.47M |
| 2013 | 5.58M | -0.40M |
| 2012 | 5.98M | -0.68M |
| 2011 | 6.66M | +0.36M |
| 2010 | 6.30M | +0.07M |
| 2009 | 6.23M | +1.29M |
| 2008 | 4.94M |